Cargando…

Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer

BACKGROUND: There is recent interest in treating locally advanced rectal cancer (LARC) patients with total neoadjuvant therapy (TNT). However, whether TNT is associated with improved overall survival (OS) remains unknown. This study compares outcomes following TNT and following neoadjuvant chemoradi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Shaoyu, Brodin, N. Patrik, English, Keara, Ohri, Nitin, Chuy, Jennifer W., Rajdev, Lakshmi N., Narang, Rahul, Kalnicki, Shalom, Guha, Chandan, Garg, Madhur K., Kabarriti, Rafi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890979/ https://www.ncbi.nlm.nih.gov/pubmed/31832617 http://dx.doi.org/10.1016/j.eclinm.2019.09.009

Ejemplares similares

Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma
por: English, Keara, et al.
Publicado: (2020)

Origin of Locoregional Recurrences After Definitive Intensity-modulated Radiation Therapy (IMRT) for Laryngeal Cancer Determined Based on Follow-up PET/CT Imaging
por: Kabarriti, Rafi, et al.
Publicado: (2019)

Reply to Chowdhary et al
por: Kabarriti, Rafi, et al.
Publicado: (2020)

Extent of Prior Lung Irradiation and Mortality in COVID-19 Patients With a Cancer History
por: Kabarriti, Rafi, et al.
Publicado: (2020)

Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York
por: Kabarriti, Rafi, et al.
Publicado: (2020)

A positron emission tomography radiomic signature for distant metastases risk in oropharyngeal cancer patients treated with definitive chemoradiotherapy
por: Brodin, N. Patrik, et al.
Publicado: (2022)

Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer
por: Brodin, N. Patrik, et al.
Publicado: (2021)

Using Statistical Measures and Density Maps Generated From Chest Computed Tomography Scans to Identify and Monitor COVID-19 Cases in Radiation Oncology Rapidly
por: Tomé, Marie-Hélène, et al.
Publicado: (2021)

Hybrid tandem and ovoids brachytherapy in locally advanced cervical cancer: impact of dose and tumor volume metrics on outcomes
por: Rivera, Amanda, et al.
Publicado: (2021)

Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: a meta-analysis
por: Bernstein, Michael B., et al.
Publicado: (2013)

Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles
por: Lee, Sung Hwan, et al.
Publicado: (2015)

Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
por: Acuna-Villaorduna, Ana, et al.
Publicado: (2022)

Predictors of Financial Toxicity in Patients Receiving Concurrent Radiation Therapy and Chemotherapy
por: Jiang, Julie M., et al.
Publicado: (2022)

Trimodal Therapy in Esophageal Squamous Cell Carcinoma: Role of Adjuvant Therapy Following Neoadjuvant Chemoradiation and Surgery
por: Li, Xiaokun, et al.
Publicado: (2022)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
por: Ferrari, Linda, et al.
Publicado: (2015)

Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients
por: Tang, Justin Y., et al.
Publicado: (2018)

Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
por: Galindo, José, et al.
Publicado: (2013)

Non-Invasive Targeted Hepatic Irradiation and SPECT/CT Functional Imaging to Study Radiation-Induced Liver Damage in Small Animal Models
por: Kabarriti, Rafi, et al.
Publicado: (2019)

Timing of Esophagectomy after Neoadjuvant Chemoradiation Therapy Affects the Incidence of Anastomotic Leaks
por: Roh, Simon, et al.
Publicado: (2019)

Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2023)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
por: Elsayed, Dalia Hamouda, et al.
Publicado: (2023)

The effect of low-dose radiation spillage during stereotactic radiosurgery for brain metastases on the development of de novo metastases
por: Paul, Shiby, et al.
Publicado: (2021)

A nomogram to preoperatively predict 1-year disease-specific survival in resected pancreatic cancer following neoadjuvant chemoradiation therapy
por: Hwang, Ho Kyoung, et al.
Publicado: (2020)

Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
por: Jeong, Duck Hyoun, et al.
Publicado: (2013)

Association of tumor differentiation and prognosis in patients with rectal cancer undergoing neoadjuvant chemoradiation therapy
por: Huang, Qunsheng, et al.
Publicado: (2019)

Evaluation and Predictive Factors of Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation Therapy
por: Kokaine, Linda, et al.
Publicado: (2021)

Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
por: Rizzo, Alessandro
Publicado: (2022)

Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy
por: Murphy, Brenna M., et al.
Publicado: (2021)

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
por: Matani, Hirsch, et al.
Publicado: (2022)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
por: Habermehl, Daniel, et al.
Publicado: (2012)

Neoadjuvant Chemoradiation Herapy for Soft Tissue Sarcomas of the Extremities
por: Aguiar, Samuel, et al.
Publicado: (2009)

Scrotal and Penile Erythrodysesthesia Associated with Neoadjuvant Capecitabine Chemoradiation
por: Dricken, Julie, et al.
Publicado: (2020)

Clinical outcome of neoadjuvant chemoradiation in rectal cancer treatment
por: Suwanthanma, Weerapat, et al.
Publicado: (2021)

Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation
por: Kane, John M., et al.
Publicado: (2018)

Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinoma
por: Kandilis, Apostolos, et al.
Publicado: (2020)

Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
por: Bao, Yongxing, et al.
Publicado: (2022)

Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction
por: Nusrath, Syed, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series
por: Hadzitheodorou, Christina, et al.
Publicado: (2017)

Endoscopic ultrasound-guided fiducial marker placement for neoadjuvant chemoradiation therapy for resectable pancreatic cancer
por: Ashida, Reiko, et al.
Publicado: (2020)

Neoadjuvant Chemoradiation Compared With Neoadjuvant Radiation Alone in the Management of High-Grade Soft Tissue Extremity Sarcomas
por: Hazell, Sarah Z., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hm0taibovmmormlpp3ko6aeiph